权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

Investigations on the impact of smart infusion pumps towards the improvement of infusion safety in the Neonatal Intensive Care Unit

智能输液泵对提高新生儿重症监护病房输液安全影响的调查

基本信息

批准号：
9806398
负责人：
Kumiko Ohashi Schnock
金额：
$ 8.95万
依托单位：
BRIGHAM AND WOMEN'S HOSPITAL
依托单位国家：
美国
项目类别：
财政年份：
2019
资助国家：
美国
起止时间：
2019-08-01 至 2021-07-31
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/9806398
关键词：
Academic Medical Centers Address Adult Area Caring Child Childhood Clinical Complex Data Collection Development Devices Effectiveness Electronic Health Record Environment Exposure to Foundations Frequencies Future Healthcare Hospitalization Hospitals Incidence Infant Information Technology Infusion Pumps Infusion procedures Injury Inpatients Institution Intravenous Investigation Measures Medical Errors Medication Errors Methods Neonatal Neonatal Intensive Care Units Outcome Patient Care Patients Pharmaceutical Preparations Phase Population Prevalence Prevention Process Pump Recommendation Research Risk Safety Severity of illness Source Standardization Technology Testing United States improved interoperability medication administration medication safety neonatal care neonatal patient patient population patient safety premature tool

项目摘要

ABSTRACT Medication errors occurring during the administration phase of the medication process may now be the most frequent type of mistake occurring in hospitals, and they have considerable potential for injury. In particular, medication errors are potentially more harmful and have a higher incidence rate in the pediatric population than in the adult population. Infants in the neonatal intensive care unit (NICU) are among the most vulnerable patient population. Smart infusion pumps (smart pumps) have been implemented to support the safe medication administration process. Although smart infusion pumps are used widely, these devices have not achieved their full safety potential, as medication administration errors persist. Additionally, the prevalence of device-related errors and their consequences for patients are still not well- defined. Like adult studies, there is a paucity of evidence demonstrating the ability of these technologies to reduce harm to pediatric inpatients. The objective of this study is to refine an existing data collection tool that has been tested in adult settings to investigate the frequency and types of IV medication errors associated with medication administration using smart pumps for neonatal care. Once we develop the data collection tool, we will conduct pilot data collection to validate the tool and to identify the current issues of medication administration with smart pumps in the NICU at one academic medical center. Through the development of the data collection tool and assessment of the preliminary results, this study will provide the foundation for a larger multisite study that will broadly define IV medication administration errors in the NICU and develop strategies to improve the prevention of IV medication administration errors in the neonatal care setting. The proposed study will provide a standardized neonatal-specific data collection tool to identify IV medication administration errors and their key factors to improve medication safety in NICUs to reduce potential harm for vulnerable neonatal infants.

抽象的在用药过程的给药阶段发生的用药错误现在可能是医院中最常发生的错误类型，并且它们有相当大的错误受伤的可能性。特别是，用药错误可能危害更大，并且会产生更大的影响。儿童人群的发病率高于成人人群。婴儿在新生儿重症监护病房 (NICU) 是最脆弱的患者群体之一。聪明的已实施输液泵（智能泵）以支持安全用药行政流程。尽管智能输液泵应用广泛，但这些设备尚未得到广泛应用。由于用药管理错误仍然存在，因此充分发挥了安全潜力。此外，与设备相关的错误的发生率及其对患者造成的后果仍不清楚定义的。与成人研究一样，缺乏证据证明这些能力减少对儿科住院患者伤害的技术。本研究的目的是完善现有的数据收集工具，该工具已在成人环境调查与以下疾病相关的静脉注射用药错误的频率和类型使用智能泵进行新生儿护理的药物管理。一旦我们开发出数据收集工具，我们将进行试点数据收集来验证该工具并确定当前的在一所学术医学中心的 NICU 中使用智能泵进行药物管理的问题中心。通过数据采集工具的开发和初步评估结果，这项研究将为更大规模的多地点研究奠定基础，该研究将广泛定义 NICU 中的静脉用药管理错误并制定改善策略预防新生儿护理环境中的静脉注射用药错误。拟议的研究将提供标准化的新生儿特定数据收集工具来识别静脉注射药物提高新生儿重症监护病房用药安全性的管理失误及其关键因素对脆弱的新生儿的潜在伤害。